Nyxoah Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Nyxoah (EBR:NYXH) Second Quarter 2024 Results

Key Financial Results

• Net loss: €13.1m (loss widened by 2.6% from 2Q 2023).
• €0.43 loss per share.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Nyxoah EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 54%. Earnings per share (EPS) exceeded analyst estimates by 14%.

Looking ahead, revenue is forecast to grow 48% p.a. on average during the next 3 years, compared to a 7.2% growth forecast for the Medical Equipment industry in Europe.

Performance of the market in Belgium.

The company's shares are down 1.5% from a week ago.

Risk Analysis

Be aware that Nyxoah is showing 3 warning signs in our investment analysis and 1 of those is a bit unpleasant...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com